Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Very low dose rivaroxaban added to dual antiplatelet therapy in acute coronary syndrome
2018-003299-11Phase 4Unknown
- Sponsor
- East and North Hertfordshire NHS Trust
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rivaroxaban in acute coronary syndrome (ACS) (3 arms), sponsored by East and North Hertfordshire NHS Trust. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2018-003299-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003299-11.